Open AccessClinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study
Author(s) -
Gianenrico Senna,
Maria Aliani,
Elena Altieri,
Pietro Bracciale,
Luisa Brussino,
Maria Filomena Caiaffa,
Paolo Cameli,
Giorgio Walter Caica,
Cristiano Caruso,
Maria D’Amato,
Fausto De Michele,
Stefano Del Giacco,
Fabiano Di Marco,
Francesco Menzella,
Girolamo Pelaia,
Paola Rogliani,
Micaela Romagnoli,
Pietro Schino,
Jan Walter Schroeder,
Alessandra Vultaggio,
Sara Rizzoli,
Alessandro Zullo,
Silvia Boarino,
Marilena Palmisano,
Alessandra Rossi,
Gianfranco Vitiello,
Stefano Centanni
Publication year - 2022
Publication title -
journal of asthma and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.162
H-Index - 30
ISSN - 1178-6965
DOI - 10.2147/jaa.s383012
Subject(s) - benralizumab , medicine , post hoc analysis , post hoc , eosinophil , clinical efficacy , mepolizumab , asthma